![Priya Singhal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Priya Singhal
Corporate Officer/Principal bei
BIOGEN INC.
Vermögen: 2 Mio $ am 31.05.2026
Profil
Priya Singhal is currently Executive Vice President & Head-Development at Biogen, Inc. since 2021.
Formerly, Dr. Singhal was Head-Medical Affairs & Vice President at Vertex Pharmaceuticals, Inc. from 2008 to 2012, VP-Clinical Trials Benefit Risk Management at Biogen, Inc. from 2012 to 2018, and Head-Research & Development at Zafgen, Inc. from 2019 to 2020.
Education includes a doctorate from the University of Mumbai and graduate studies at Harvard T.H.
Chan School of Public Health.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BIOGEN INC. 0.01% | 21.04.2026 | 8’043 ( 0.01% ) | 2 Mio $ | 31.05.2026 |
Aktive Positionen von Priya Singhal
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Priya Singhal
| Unternehmen | Position | Ende |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2020 |
| BIOGEN INC. | Corporate Officer/Principal | 01.01.2018 |
| VERTEX PHARMACEUTICALS INCORPORATED | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2012 |
Ausbildung von Priya Singhal
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
77
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
University of Mumbai
 University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard T.H. Chan School of Public Health
 Harvard T.H. Chan School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
